Total Funding
32
39
Total FundingSeries B raised
Growth Score 32 in past quarter
-3 pts
Heat Score 39 in past quarter
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
196020
ICM develops a gene theraphy aimed to combat osteoarthritis and age-related mascular disease.
- Jeffrey Berg: Chairman and CEO
